Hermetica Superfood Encyclopedia
The Short Answer
A naturally dominant gut bacterium in breastfed infants that is clinically proven to relieve IBS symptoms in adults and plays a critical role in early immune and digestive development.
CategoryProbiotic & Fiber
GroupFermented/Probiotic
Evidence LevelModerate
Synergy Pairings4
Health Benefits
Restores and maintains gut microbiota equilibrium, supporting optimal digestion and nutrient assimilation.
Stimulates robust mucosal immune responses and enhances systemic immunity to defend against infections.
Reduces intestinal and systemic inflammation by effectively modulating cytokine profiles.
Promotes the healthy development of the infant gut, brain, and immune system, particularly through HMO metabolism.
Positively influences the gut-brain axis, potentially alleviating symptoms of mood disorders, anxiety, and depression.
Eases symptoms of irritable bowel syndrome (IBS), bloating, and irregularity by improving gut motility and reducing visceral hypersensitivity.
Origin & History
*Bifidobacterium infantis*, a subspecies of *Bifidobacterium longum*, is a naturally occurring probiotic strain foundational to the gastrointestinal tract of breastfed infants. Native to the human gut microbiome, it specializes in digesting human milk oligosaccharides (HMOs), making it critical for early-life development. Extensively studied for its profound role in digestive, immune, and neurological health, it is now widely utilized in both pediatric and adult probiotic formulations.
“Modern biochemical compound without traditional medicinal history. While *Bifidobacterium infantis* itself is a modern scientific discovery, the understanding of its critical role in neonatal health, particularly in breastfed infants, has historical roots in observing healthy infant development. Its profound impact on the gut-immune-brain axis has propelled its modern use from early development to adult gut health, making it a cornerstone of contemporary probiotic science.”Traditional Medicine
Scientific Research
Extensive research, including numerous clinical trials, demonstrates *Bifidobacterium infantis*'s ability to restore healthy gut microbiota and improve intestinal barrier integrity. Studies confirm its significant immunomodulatory effects, including Treg stimulation and reduced pro-inflammatory cytokines, which contribute to its anti-inflammatory properties. Furthermore, documented improvements in IBS symptoms, reduced colonic inflammation, and increased short-chain fatty acid production highlight its broad therapeutic potential.
Preparation & Dosage
Supplements
Consume 1–10 billion CFU daily in capsule or powder form for comprehensive digestive, immune, and inflammatory support.
Powder Form
Easily mixed into milk, water, or smoothies, suitable for both adults and infants.
Fortified Foods
Incorporated into yogurts, kefirs, and other functional beverages for daily probiotic intake.
Infant-Specific Forms
Available as oral suspensions or powders specifically designed for developing microbiota in newborns.
Nutritional Profile
- Probiotic Strain: *Bifidobacterium infantis*, a key beneficial bacterium specializing in human milk oligosaccharide (HMO) digestion.
- Enzyme Systems: Capable of degrading complex carbohydrates, including HMOs, to enhance nutrient uptake and provide energy for other beneficial bacteria.
- Short-Chain Fatty Acids (SCFAs): Produces butyrate, acetate, and propionate, which nourish colonocytes, reduce inflammation, and support gut barrier integrity.
- Bioactive Metabolites: Modulates cytokine profiles and enhances colonization resistance against pathogens.
Synergy Stack
Hermetica Formulation Heuristic
Microbiome modulator
Gut & Microbiome | Immune & Inflammation
Frequently Asked Questions
What is Bifidobacterium infantis?
Bifidobacterium infantis (formally B. longum subsp. infantis) is a probiotic bacterium that is the dominant species in the gut of breastfed infants. It uniquely specializes in digesting human milk oligosaccharides (HMOs) and plays a foundational role in infant immune and digestive development. The strain B. infantis 35624 is widely studied for IBS in adults.
What is the recommended dosage of Bifidobacterium infantis for IBS?
The most studied dosage for IBS is 1 billion CFU/day of the B. infantis 35624 strain (marketed as Align or Alflorex), which demonstrated significant reductions in abdominal pain, bloating, and bowel dysfunction in a landmark randomized controlled trial published in the American Journal of Gastroenterology. Higher doses have not consistently shown additional benefit for IBS.
How does Bifidobacterium infantis differ from other Bifidobacterium species?
B. infantis is uniquely adapted to the infant gut through its ability to fully metabolize all human milk oligosaccharides (HMOs), a capability most other Bifidobacterium species lack. In adults, the 35624 strain has the strongest clinical evidence for IBS symptom relief among all Bifidobacterium strains, with demonstrated effects on reducing pro-inflammatory cytokines like IL-6 and TNF-alpha.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
